Structure |
Chemical Name |
CAS |
MF |
![Prednicarbate Impurity B](/) |
Prednicarbate Impurity B |
|
|
![Doxofylline Impurity 13](/) |
Doxofylline Impurity 13 |
|
|
![Canagliflozin Impurity 60](/) |
Canagliflozin Impurity 60 |
|
|
![Canagliflozin Impurity 65](/) |
Canagliflozin Impurity 65 |
|
|
![Rosuvastatin Impurity 75](/) |
Rosuvastatin Impurity 75 |
|
|
![Selexipag Impurity 6](/) |
Selexipag Impurity 6 |
|
|
![Cabozantinib impurity N](/) |
Cabozantinib impurity N |
|
|
![Barcitinib impurity-09](/CAS/20210111/GIF/1187594-16-6.gif) |
Barcitinib impurity-09 |
1187594-16-6 |
C14H13N7 |
![Rotigotine Impurity 6](/) |
Rotigotine Impurity 6 |
|
|
![Olprinone Impurity 7](/CAS/20210111/GIF/2236020-10-1.gif) |
Olprinone Impurity 7 |
2236020-10-1 |
C9H10N2 |
![Cilastatin Impurity 2](/) |
Cilastatin Impurity 2 |
|
|
![Cilastatin Impurity 7](/) |
Cilastatin Impurity 7 |
|
|
![Dabrafenib Impurity 1](/CAS/20210111/GIF/1907654-22-1.gif) |
Dabrafenib Impurity 1 |
1907654-22-1 |
C24H21F3N4O3S2 |
![Trelagliptin Impurity SJ](/CAS/20210111/GIF/2087874-94-8.gif) |
Trelagliptin Impurity SJ |
2087874-94-8 |
C40H42F2N10O6 |
![Eliglustat Impurity 2(Eliglustat SR-Isomer)](/CAS/20200611/GIF/1092472-66-6.gif) |
Eliglustat Impurity 2(Eliglustat SR-Isomer) |
1092472-66-6 |
C23H36N2O4 |
![Tamsulosin impurity C](/CAS/20200331/GIF/CB44904537.gif) |
Tamsulosin impurity C |
|
C20H28N2O5S |
![Umeclidinium Bromide Impurity 9 DiHCl](/CAS/20210305/GIF/494778-36-8.gif) |
Umeclidinium Bromide Impurity 9 DiHCl |
494778-36-8 |
C18H32N2O4 |
![Flucloxacillin Impurity 4](/) |
Flucloxacillin Impurity 4 |
|
|
![Ipratropium bromide Impurity 4](/CAS/20200331/GIF/CB44904603.gif) |
Ipratropium bromide Impurity 4 |
|
C20H29Br2NO3 |
![Cefminox Impurity 6](/) |
Cefminox Impurity 6 |
|
|
![Afatinib Impurity 55](/) |
Afatinib Impurity 55 |
|
|
![Brivaracetam Impurity 9](/) |
Brivaracetam Impurity 9 |
|
|
![Etoricoxib Impurity 40](/) |
Etoricoxib Impurity 40 |
|
|
![Lenvatinib Impurity 31](/) |
Lenvatinib Impurity 31 |
|
|
![Oseltamivir Impurity 35](/CAS/20200611/GIF/757965-01-8.gif) |
Oseltamivir Impurity 35 |
757965-01-8 |
C14H22O4 |
![Palbociclib Impurity 39](/) |
Palbociclib Impurity 39 |
|
|
![Posaconazole Impurity 75](/) |
Posaconazole Impurity 75 |
|
|
![Rabeprazole Impurity 22](/) |
Rabeprazole Impurity 22 |
|
|
![Sunitinib Impurity 12](/) |
Sunitinib Impurity 12 |
|
|
![Ticagrelor Impurity 113](/) |
Ticagrelor Impurity 113 |
|
|
![Ticagrelor Impurity 97](/) |
Ticagrelor Impurity 97 |
|
|
![Tofacitinib Impurity 117](/) |
Tofacitinib Impurity 117 |
|
|
![Trelagliptin Impurity 22](/) |
Trelagliptin Impurity 22 |
|
|
![Trelagliptin Impurity 29](/) |
Trelagliptin Impurity 29 |
|
|
![Vildagliptin Impurity 43](/) |
Vildagliptin Impurity 43 |
|
|
![Dexchlorpheniramine impurity F](/) |
Dexchlorpheniramine impurity F |
|
|
![Irbesartan IMpurity F](/CAS/20200331/GIF/CB44918336.gif) |
Irbesartan IMpurity F |
|
C25H28N6O |
![Itraconazole iMpurity 2](/) |
Itraconazole iMpurity 2 |
|
|
![Palbociclib Impurity 6](/) |
Palbociclib Impurity 6 |
|
|
![Saxagliptin Impurity 5](/) |
Saxagliptin Impurity 5 |
|
|
![Cinacalcet Impurity 18](/) |
Cinacalcet Impurity 18 |
|
|
![Erlotinib Impurity 23](/CAS/20211123/GIF/2021249-11-4.gif) |
Erlotinib Impurity 23 |
2021249-11-4 |
C23H18F6N6O |
![Erlotinib Impurity 36](/) |
Erlotinib Impurity 36 |
|
|
![Fasudil Impurity 17](/) |
Fasudil Impurity 17 |
|
|
![Febuxostat Impurity 50](/) |
Febuxostat Impurity 50 |
|
|
![Varenicline Impurity 8](/) |
Varenicline Impurity 8 |
|
|
![Ticagrelor Impurity 53](/) |
Ticagrelor Impurity 53 |
2750247-77-7 |
|
![Edoxaban Impurity 5](/) |
Edoxaban Impurity 5 |
|
|
![Edoxaban Impurity 11](/) |
Edoxaban Impurity 11 |
|
|
![Empagliflozin Impurity 5](/CAS/20211123/GIF/1800196-46-6.gif) |
Empagliflozin Impurity 5 |
1800196-46-6 |
C17H16ClIO3 |
![Carfilzomib Impurity 2](/) |
Carfilzomib Impurity 2 |
|
|
![Oseltamivir Impurity 20](/CAS/20210305/GIF/212504-90-0.gif) |
Oseltamivir Impurity 20 |
212504-90-0 |
C12H22N2O3 |
![Febuxostat Impurity 61](/) |
Febuxostat Impurity 61 |
|
|
![1-cyclopropyl-6,8-dimethoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo [3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic](/CAS/20211123/GIF/2252446-68-5.gif) |
1-cyclopropyl-6,8-dimethoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo [3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic |
2252446-68-5 |
C22H28ClN3O5 |
![CINACALCET-001-R](/CAS/20211123/GIF/1630761-22-6.gif) |
CINACALCET-001-R |
1630761-22-6 |
C11H11BF4N4O |
![Cefotiam Impurity D](/) |
Cefotiam Impurity D |
|
|
![Peramivir Impurity B](/) |
Peramivir Impurity B |
|
|
![AztreonaM IMpurity C](/) |
AztreonaM IMpurity C |
|
|
![Pramipexole Related Impurity 3](/CAS/20200611/GIF/2166216-34-6.gif) |
Pramipexole Related Impurity 3 |
2166216-34-6 |
C10H17N3OS |
![Lincomycin sulfoxide Impurity 5](/) |
Lincomycin sulfoxide Impurity 5 |
|
|
![Sulpiride Impurity 4](/) |
Sulpiride Impurity 4 |
|
|
![Tacrolimus Impurity E](/) |
Tacrolimus Impurity E |
|
|
![Bumetanide iMpurity E](/) |
Bumetanide iMpurity E |
|
|
![2-クロロトリチルアルコール](/CAS/GIF/66774-02-5.gif) |
2-クロロトリチルアルコール |
66774-02-5 |
C19H15ClO |
![プレドニカルベート関連化合物A (1,2-DIHYDROPREDNI1,2-ジヒドロプレドニカルベート](/CAS/20150408/GIF/671225-26-6.gif) |
プレドニカルベート関連化合物A (1,2-DIHYDROPREDNI1,2-ジヒドロプレドニカルベート |
671225-26-6 |
C27H38O8 |
![開環アゼトレオナム](/CAS/GIF/87500-74-1.gif) |
開環アゼトレオナム |
87500-74-1 |
C13H19N5O9S2 |
![Methyl 2-Acetyl-3-(3-nitrophenyl)-5-oxo-hexanoate](/CAS/20200119/GIF/CB45044957.gif) |
Methyl 2-Acetyl-3-(3-nitrophenyl)-5-oxo-hexanoate |
2469555-30-2 |
C15H17NO6 |
![Clonidine Related Compound A (1-acetyl-2-(2,6-dichlorophenylimino)imidazolidine)](/CAS/20150408/GIF/54707-71-0.gif) |
Clonidine Related Compound A (1-acetyl-2-(2,6-dichlorophenylimino)imidazolidine) |
54707-71-0 |
C11H11Cl2N3O |
![Mupirocin iMpurity 2](/CAS/20200331/GIF/CB45417652.gif) |
Mupirocin iMpurity 2 |
|
C26H44O9 |
![Ceftriaxone Sodium impurity 5](/) |
Ceftriaxone Sodium impurity 5 |
|
|
![Sugammadex sodium Org48302 Impurity](/) |
Sugammadex sodium Org48302 Impurity |
|
|
![176761-00-5](/CAS/20200611/GIF/176761-00-5.gif) |
176761-00-5 |
176761-00-5 |
C17H15FN2O5 |
![Pramipexole Impurity W](/) |
Pramipexole Impurity W |
|
|
![Oseltamivir Impurity 26](/) |
Oseltamivir Impurity 26 |
241465-24-7 |
|
![Moxifloxacin Impurity 5](/) |
Moxifloxacin Impurity 5 |
|
|
![Moxifloxacin Impurity 24](/) |
Moxifloxacin Impurity 24 |
|
|
![Fosaprepitant Impurity 1](/) |
Fosaprepitant Impurity 1 |
|
|
![Ticagrelor Impurity 1](/) |
Ticagrelor Impurity 1 |
|
|
![2,2'-(4,10-bis((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid](/) |
2,2'-(4,10-bis((2S,3R)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid |
|
|
![Loratadine Impurity 2](/CAS/20200611/GIF/167891-69-2.gif) |
Loratadine Impurity 2 |
167891-69-2 |
C22H25ClN2O2 |
![Eliglustat (1S,2S)-Isomer (Hemitartrate)](/CAS/20200611/GIF/1092472-70-2.gif) |
Eliglustat (1S,2S)-Isomer (Hemitartrate) |
1092472-70-2 |
C23H36N2O4 |
![3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-](/CAS/20210111/GIF/2271228-52-3.gif) |
3-Azetidineacetic acid, 1-(ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]- |
2271228-52-3 |
C16H18N6O4S |
![Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)-](/CAS/20210111/GIF/2412376-06-6.gif) |
Cyclopentanecarboxylic acid, 3-[(1S)-1-amino-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3S,4R)- |
2412376-06-6 |
C13H26N4O3 |
![Peramivir Impurity 49](/) |
Peramivir Impurity 49 |
2758048-81-4 |
|
![1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[[(3-carboxyphenyl)amino]carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)-](/CAS/20211123/GIF/1401451-19-1.gif) |
1-Pyrrolidinecarboxylic acid, 3,3'-dithiobis[5-[[(3-carboxyphenyl)amino]carbonyl]-, 1,1'-bis[(4-nitrophenyl)methyl] ester, (3S,3'S,5S,5'S)- |
1401451-19-1 |
C40H36N6O14S2 |
![Benzeneacetic acid, α-(hydroxymethyl)-, 9-butyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, [7(S)-(1α,2β,4β,5α,7β)]- (9CI)](/CAS/20210305/GIF/14861-14-4.gif) |
Benzeneacetic acid, α-(hydroxymethyl)-, 9-butyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl ester, [7(S)-(1α,2β,4β,5α,7β)]- (9CI) |
14861-14-4 |
C20H27NO4 |
![Cisatracurium besylate impurity 18](/) |
Cisatracurium besylate impurity 18 |
|
|
![Paclitaxel Impurity1 ABCDEFGHJKL](/) |
Paclitaxel Impurity1 ABCDEFGHJKL |
|
|
![3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1)](/CAS/GIF/116817-26-6.gif) |
3-THIOPHENEPROPANAMINE, N,N-DIMETHYL-GAMMA-(1-NAPHTHALENYLOXY)-, ETHANEDIOATE(1:1) |
116817-26-6 |
C21H23NO5S |
![(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol](/CAS/GIF/182230-43-9.gif) |
(2R,3S/2S,3R)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol |
182230-43-9 |
C16H14F3N5O |
![Bumetanide Impurity 8](/) |
Bumetanide Impurity 8 |
|
|
![Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy-](/CAS/20210305/GIF/448184-52-9.gif) |
Benzenesulfonamide, N-(2-aminoethyl)-3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2-yl)-4-ethoxy- |
448184-52-9 |
C19H26N6O4S |
![Latamoxef Impurity C](/) |
Latamoxef Impurity C |
|
|
![Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI)](/CAS/20210305/GIF/31301-86-7.gif) |
Carbamic acid, [2-hydroxy-1-methyl-2-[3-(phenylmethoxy)phenyl]ethyl]-, phenylmethyl ester, [R-(R*,S*)]- (9CI) |
31301-86-7 |
C24H25NO4 |
![β-メチル-6-アミノ-9H-プリン-9-エタノール](/CAS/20211123/GIF/20776-34-5.gif) |
β-メチル-6-アミノ-9H-プリン-9-エタノール |
20776-34-5 |
C8H11N5O |
![5-(3,4,5-トリメトキシベンジル)-2-アミノピリミジン-4-オール](/CAS/GIF/92440-76-1.gif) |
5-(3,4,5-トリメトキシベンジル)-2-アミノピリミジン-4-オール |
92440-76-1 |
C14H17N3O4 |
![(S)-3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino) propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride](/) |
(S)-3-(3-((3-chloro-2-(3,4-dimethoxyphenyl)propyl)(methyl)amino) propyl)-7,8-dimethoxy-1,3,4,5-tetrahydro-2H-benzo[d]azepin-2-one hydrochloride |
|
|
![(2R,3R)-3-amino-2-methyl-4-oxoazetidine-1-sulfonic acid](/) |
(2R,3R)-3-amino-2-methyl-4-oxoazetidine-1-sulfonic acid |
|
|
![Osimertinib impurity01](/) |
Osimertinib impurity01 |
|
|
![Hexanoic acid, 6-chloro-3,5-dihydroxy-, (3R,5S)-](/CAS/20210305/GIF/958358-67-3.gif) |
Hexanoic acid, 6-chloro-3,5-dihydroxy-, (3R,5S)- |
958358-67-3 |
C6H11ClO4 |